Group Videoconferencing Intervention to Improve Maternal Sensitivity

March 27, 2023 updated by: Pontificia Universidad Catolica de Chile

Group Videoconferencing Intervention to Improve Maternal Sensitivity in Mother-infant Dyads in Primary Care in Chile : Randomized Controlled Feasibility Trial

Background: Early childhood development is highly dependent on the sensitive care provided by their caregivers . Interventions focused on supporting parents to improve their sensitivity have been shown to be effective . The COVID-19 pandemic has had a great impact on mental health , with pregnant women and mothers of children under one year of age being an especially vulnerable group . On the other hand, access to mental health interventions in person is restricted by confinement measures , especially group interventions, so it is relevant to have remote interventions that support this group of mothers.

Objectives: to evaluate the feasibility and acceptability of a group videoconferencing intervention to improve maternal sensitivity aimed at mother / infant dyads attended in Primary Health Care in Chile Methodology: a randomized pilot feasibility study will be carried out with a mixed design with quantitative and qualitative evaluations. A face-to-face group intervention with proven effectiveness will be adapted to videoconferencing format , then 50 dyads will be randomized in a 3: 2 ratio to receive the videoconferencing intervention ( n=30) or the delivery of educational brochures (n=20) . The feasibility and acceptability will be evaluated assessing the participation, adherence and satisfaction in a quantitative way, in addition the qualitative evaluation will be carried out through interviews and focus groups. Changes in clinical outcomes will also be evaluated: maternal sensitivity, depressive symptoms, postnatal maternal attachment and infant socio-emotional development. This pilot study will allow the identification of the key parameters for the implementation and evaluation of the intervention, which will allow the design of an effectiveness study in the future.

Study Overview

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Santiago, Chile, 7610682
        • CESFAM Juan Pablo Segundo ANCORA UC Christus
      • Santiago, Chile, 7610682
        • CESFAM Madre Teresa Calcuta ANCORA UC Christus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Mother of a baby between 4 months and a year
  • Attended at one of the participating primary care health centers
  • Older than 18 years-old
  • Handling Spanish fluently
  • Have an electronic device that allows videoconferencing (computer, tablet or smart cell phone)

Exclusion Criteria:

  • Mother with severe intellectual deficit or psychotic symptoms
  • Participate in another early intervention at the health care center

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Videoconference Intervention group
Brief group videoconferencing attachment-based intervention (sessions once a week for 4 weeks)
A short face-to-face dyadic group workshop focused on increasing maternal sensitivity was adapted to be carried out virtually by videoconference. The intervention considers 4 sessions, with a weekly frequency, with a minimum of 3 and a maximum of 6 dyads per group led by a monitor (psychologist). The activities are protocolized in a manual and are designed to be carried out by the mother with the baby under one year of age. .
Active Comparator: Control group
Psycho-educational intervention : They will receive brochures with information on parenting (once a week for 4 weeks)
Psycho-educational intervention : They will receive brochures with information on parenting (once a week for 4 weeks) in addition to the usual care in their primary care center

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of the intervention: eligibility rates
Time Frame: Through study completion, approximately 18 months
percentage of eligible population that is recruitable: meets inclusion and not exclusion criteria
Through study completion, approximately 18 months
Feasibility of the intervention: attrition rates
Time Frame: Through study completion, approximately 18 months
Attrition and follow-up rates by treatment condition.
Through study completion, approximately 18 months
Feasibility of the intervention: recruitment rates
Time Frame: Through study completion, approximately 18 months
percentage that meets entry criteria and agrees to participate
Through study completion, approximately 18 months
Acceptability of the intervention : participation rates
Time Frame: Through study completion, approximately 18 months
Proportion of performed sessions versus planned sessions.
Through study completion, approximately 18 months
Acceptability of the intervention : Satisfaction with the intervention
Time Frame: Through study completion, approximately 18 months
Credibility/Expectancy Questionnaire (CEQ).Scores range from 0 to 100 with higher scores indicating higher acceptability of the intervention.
Through study completion, approximately 18 months
Acceptability of the intervention (qualitative assessment)
Time Frame: Through study completion, approximately 18 months
Semi-structured interviews with monitors of the intervention (two psychologists) and focus groups with participating mothers (7 in total) with the aim of collecting information about the experience and identifying possible improvements
Through study completion, approximately 18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Maternal sensitivity
Time Frame: Through study completion, approximately 18 months
Adult Sensitivity Scale (E.S.A.) rubric with 19 indicators, each indicator is scored between 1 and 3, and a higher score indicates higher sensitivity
Through study completion, approximately 18 months
Change in Maternal Depressive Symptoms
Time Frame: Through study completion, approximately 18 months
Edinburgh Postnatal Depression Scale (EPDS). Scores range from 0 to 30, with higher scores meaning higher depressive symptomatology.
Through study completion, approximately 18 months
Change in Children Socio Emotional Development
Time Frame: Through study completion, approximately 18 months
Ages and Stages Questionnaire (ASQ-SE). Scores range from 0 to 75 with higher scores meaning lower socio-emotional development
Through study completion, approximately 18 months
Change in postnatal maternal bonding
Time Frame: Evaluation at study entry (T0) and at the end of the intervention (T1)
Maternal postnatal attachment scale (MPAS) : is a 19-item, self-report measure have 19 items, ranging from 1 (low bonding) to 5 (high bonding),
Evaluation at study entry (T0) and at the end of the intervention (T1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2021

Primary Completion (Actual)

December 30, 2022

Study Completion (Actual)

December 30, 2022

Study Registration Dates

First Submitted

May 17, 2021

First Submitted That Met QC Criteria

May 23, 2021

First Posted (Actual)

May 27, 2021

Study Record Updates

Last Update Posted (Actual)

March 29, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • INTERDISCIPLINA II20029

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parent-Child Relations

Clinical Trials on Videoconference intervention group

Subscribe